Concourse Financial Group Securities, Inc. Xenon Pharmaceuticals Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $1.64 Billion
- Q3 2024
A detailed history of Concourse Financial Group Securities, Inc. transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 2,000 shares of XENE stock, worth $76,620. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,000
Previous 2,000
-0.0%
Holding current value
$76,620
Previous $77,000
1.3%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding XENE
# of Institutions
212Shares Held
70.2MCall Options Held
88.3KPut Options Held
28.8K-
Avoro Capital Advisors LLC New York, NY5.67MShares$217 Million3.36% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.6MShares$176 Million1.77% of portfolio
-
Wellington Management Group LLP Boston, MA3.84MShares$147 Million0.03% of portfolio
-
Braidwell LP Stamford, CT2.71MShares$104 Million3.02% of portfolio
-
Commodore Capital LP New York, NY2.7MShares$103 Million9.03% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.39B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...